Vancouver, British Columbia–(Newsfile Corp. – June 26, 2026) – Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo Genomics“), a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal telomeres, announces that the investor relations consulting agreement with Sheridan Adams, …
Read More »
Matribhumi Samachar English